The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 11, 2020
Filed:
Dec. 16, 2016
Applicants:
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
University of Washington, Seattle, WA (US);
Inventors:
Keith L. Knutson, Jacksonville, FL (US);
Mary L. Disis, Renton, WA (US);
John D. Fikes, San Diego, CA (US);
Melanie Beebe, Apex, NC (US);
Glenn Ishioka, San Diego, CA (US);
Assignees:
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
University of Washington, Seattle, WA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 9/127 (2006.01); C07K 14/47 (2006.01); C07K 14/71 (2006.01); C07K 7/08 (2006.01); C07K 14/705 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/71 (2013.01); C07K 7/08 (2013.01); C07K 14/4738 (2013.01); C07K 14/4743 (2013.01); C07K 14/4748 (2013.01); C07K 14/70503 (2013.01); A61K 38/00 (2013.01); A61K 2039/572 (2013.01);
Abstract
The present invention provides HLA-DR (MHC class II) binding peptides derived from the ovarian/breast cancer associated antigens, Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. The immunogenic peptides can be used in cancer vaccines.